Key Developments For TomoTherapy Incorporated
TomoTherapy Incorporated (TOMO.O) (Nasdaq)
TomoTherapy Incorporated Announces Treating Of Patients With TomoDirect radiation Therapy
TomoTherapy Incorporated announced that the first patients are being treated with the TomoDirect radiation therapy delivery mode at the University of Virginia Cancer Center. The addition of the TomoDirect modality to the TomoTherapy platform gives clinicians an efficient new option that expands their ability to fight cancer. TomoDirect is a non-rotational delivery mode developed as a clinical complement to the TomoHelical continuous 360-degree delivery mode. The TomoDirect delivery option enables users to quickly plan and deliver advanced TomoTherapy radiation treatments with a series of linear beam paths, rather than a single helical delivery path. TomoDirect and TomoHelical delivery modes both utilize the same binary multi-leaf collimator and CT-style gantry technology unique to the TomoTherapy platform.
TomoTherapy Incorporated Issues Q4 2009 Outlook; Revenue Outlook Above Estimates; Reaffirms FY 2009 Revenue Outlook; Raises Low End Of Prior FY 2009 Earnings Outlook To A Range In Line With Estimates
TomoTherapy Incorporated announced that for the fourth quarter of 2009, it anticipates revenue of $50 to $70 million and a loss per share in the range of $0.06 to $0.23. This would result in fiscal 2009 revenue in the previously announced range of $155 to $175 million and a narrowing of loss to the range of $0.73 to $0.90 per share from the previously announced range of $0.65 to $0.90 per share. Both the fourth quarter and fiscal 2009 loss per share ranges include the impact of the $0.04 total restructuring charge. According to Reuters Estimates, analysts on an average were expecting the Company to report loss per share of $0.14 on revenue of $49 million for the fourth quarter of 2009; loss per share of $0.74 on revenue of $161 million for fiscal 2009.
Institute Curie Hospital Purchases Second TomoTherapy Radiation Therapy System From TomoTherapy Incorporated
TomoTherapy Incorporated announced that Institute Curie Hospital in France has purchased a second TomoTherapy radiation therapy system, to support the increasing demand for intensity-modulated radiation therapy (IMRT).
TomoTherapy Incorporated's TomoTherapy Radiation Therapy System Installed In Peoria, Ill
TomoTherapy Incorporated announced that a new TomoTherapy radiation therapy system has been installed in Peoria, Ill., at a facility jointly developed by Methodist Medical Center and Midwest Urological Group. The center is currently treating approximately 25 patients a day on the TomoTherapy system, which integrates true CT-based image guidance for increased treatment accuracy and helical radiation delivery for enhanced tumor targeting. Although the new TomoTherapy system may eventually be used to treat other cancers at this site, it will primarily be used to treat prostate cancer.
Moses Cone Regional Cancer Center Installs TomoTherapy Incorporated 's TomoTherapy Treatment System
TomoTherapy Incorporated announced that Moses Cone Health System has installed TomoTherapy cancer treatment system at the Moses Cone Regional Cancer Center in Greensboro, N.C. The TomoTherapy system is a radiation therapy device that integrates true CT-based image guidance for increased treatment accuracy and helical delivery for enhanced tumor targeting.
